Cwm LLC Sells 8,030 Shares of Intuitive Surgical, Inc. $ISRG

Key Points

• Cwm LLC reduced its stake in **Intuitive Surgical, Inc.** by **16.4%** in the second quarter, selling **8,030 shares** and holding **41,002 shares** worth about **$22.28 million** afterward.
• Insider transactions included **Gary S. Guthart** selling **29,360 shares** for approximately **$13.87 million**, reducing his ownership by **59.69%**, and **Amy L. Ladd** selling **336 shares**, a **23.83%** decrease in holdings.
• The stock has an average target price of **$589.43**, with **14 analysts rating it as a Buy**, **7 as Hold**, and **1 as Sell**, reflecting a **Moderate Buy** rating overall.

Cwm LLC lowered its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 16.4% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 41,002 shares of the medical equipment provider's stock after selling 8,030 shares during the quarter. Cwm LLC's holdings in Intuitive Surgical were worth $22,281,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently made changes to their positions in ISRG. Aaron Wealth Advisors LLC grew its holdings in shares of Intuitive Surgical by 0.8% during the 2nd quarter. Aaron Wealth Advisors LLC now owns 2,528 shares of the medical equipment provider's stock worth $1,374,000 after purchasing an additional 19 shares during the period. Crown Wealth Group LLC boosted its holdings in Intuitive Surgical by 4.8% in the first quarter. Crown Wealth Group LLC now owns 440 shares of the medical equipment provider's stock worth $218,000 after purchasing an additional 20 shares during the period. FSM Wealth Advisors LLC grew its holdings in shares of Intuitive Surgical by 3.8% during the first quarter. FSM Wealth Advisors LLC now owns 546 shares of the medical equipment provider's stock valued at $270,000 after purchasing an additional 20 shares during the last quarter. CFO4Life Group LLC grew its position in Intuitive Surgical by 4.8% in the 1st quarter. CFO4Life Group LLC now owns 436 shares of the medical equipment provider's stock worth $216,000 after purchasing an additional 20 shares during the last quarter. Finally, J. W. Coons Advisors LLC lifted its holdings in Intuitive Surgical by 1.4% in the first quarter. J. W. Coons Advisors LLC now owns 1,497 shares of the medical equipment provider's stock worth $741,000 after purchasing an additional 20 shares during the period. Hedge funds and other institutional investors own 83.64% of the company's stock.

Insiders Place Their Bets

In related news, insider Gary S. Guthart sold 29,360 shares of the stock in a transaction that occurred on Friday, August 29th. The shares were sold at an average price of $472.49, for a total value of $13,872,306.40. Following the completion of the transaction, the insider owned 19,827 shares of the company's stock, valued at $9,368,059.23. This represents a 59.69% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Amy L. Ladd sold 336 shares of the business's stock in a transaction dated Wednesday, September 3rd. The stock was sold at an average price of $470.11, for a total value of $157,956.96. Following the sale, the director owned 1,074 shares in the company, valued at approximately $504,898.14. This trade represents a 23.83% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 45,224 shares of company stock worth $21,716,492 in the last quarter. Corporate insiders own 0.70% of the company's stock.

Analyst Upgrades and Downgrades

ISRG has been the topic of several research reports. Deutsche Bank Aktiengesellschaft reaffirmed a "sell" rating on shares of Intuitive Surgical in a report on Friday, August 22nd. Wall Street Zen upgraded Intuitive Surgical from a "hold" rating to a "buy" rating in a research note on Saturday, October 4th. Wells Fargo & Company lifted their price objective on shares of Intuitive Surgical from $559.00 to $599.00 and gave the company an "overweight" rating in a research note on Wednesday, July 23rd. Weiss Ratings reaffirmed a "hold (c+)" rating on shares of Intuitive Surgical in a research report on Wednesday, October 8th. Finally, Erste Group Bank reaffirmed a "hold" rating on shares of Intuitive Surgical in a research report on Wednesday, July 23rd. Fourteen investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average target price of $589.43.

Intuitive Surgical Stock Down 3.2%

Shares of ISRG stock opened at $429.59 on Monday. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $616.00. The firm has a fifty day moving average of $458.68 and a 200-day moving average of $497.84. The firm has a market capitalization of $154.00 billion, a price-to-earnings ratio of 59.91, a price-to-earnings-growth ratio of 4.51 and a beta of 1.61.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.93 by $0.26. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The company had revenue of $2.44 billion for the quarter, compared to the consensus estimate of $2.35 billion. During the same period last year, the company earned $1.78 earnings per share. The firm's revenue was up 21.4% compared to the same quarter last year. Research analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.